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In conclusion, we suggest that both VDR and CaSR might be useful as molecular markers for predicting treatment outcomes and identifying the CRC patient subgroups who might benefit from 5-FU-based chemotherapy combined with vitamin D analog.
Abbreviations: CaSR, calcium-sensing receptor; CDKs, cyclin-dependent kinases; CDKI, cyclin-dependent kinase inhibitor; CDKIs, cyclin-dependent kinase inhibitors; CH2THF, 5,10-methylenetetrahydrofolate; CRC, colorectal cancer; EMT, epithelial-mesenchymal transition; FdUMP, fluorodeoxyuridine monophosphate; HSP90, heat shock protein 90; Rb, retinoblastoma protein; RXR, retinoid X receptor; TS, thymidylate synthase; VDA, vitamin D A C C E P T E D M A N U S C R I P T
Introduction
Despite the refined surgery and novel medicines that have been introduced in the clinical setting in the last decades CRC is still one of the leading causes of cancer-related deaths worldwide [1, 2] . Thus, there is an urgent need to improve existing therapeutic strategies and search for new substances that could enhance the activity of anticancer drugs. 5-FU is the chemotherapeutic drug that is most frequently used in the treatment of patients with CRC stages II, III and IV, but unfortunately it shows limited efficacy. In our previous in vivo studies we demonstrated that VDAs, especially tacalcitol [(24R)-1,24-dihydroxyvitamin D3, PRI-2191], significantly enhance the anticancer activity of 5-FU in murine MC38 and human HT-29 CRC model [3, 4] . This effect was observed at the level of tumor growth inhibition [3, 4] , prolongation of mice survival time and decrease of lymph node metastasis compared to 5-FU applied alone [3] . Furthermore, increasing evidence shows improved anticancer efficacy of 5-FU towards CRC cells when it is combined with an active metabolite of vitamin D or its analogs [5] [6] [7] [8] .
For many years vitamin D has raised a great interest due to its role in the prevention of CRC development and its anticancer properties [9, 10] . The biologically active form of vitamin D3 [1α,25-dihydroxyvitamin D3, 1α,25(OH)2D3, calcitriol] regulates the transcription of multiple genes through the VDR which heterodimerizes with the retinoid X receptor (RXR).
The VDR-RXR complex binds to specific DNA sequences (vitamin D response elements (VDREs)) in the target genes promoters resulting in the regulation of their expression and A C C E P T E D M A N U S C R I P T consequently in the control of CRC cells growth, differentiation and survival [11] . However, it cannot be used in the clinical practice as an anticancer drug because of its high calcemic activity.
Therefore, VDAs which show the same or higher anticancer activity and lower toxicity than calcitriol are being synthesized and tested. Previously, we demonstrated that PRI-2191 has better anticancer properties and less calcemic activity compared to calcitriol [12] . Saramäki et al. have shown that CDKN1A gene which encodes the cyclin-dependent kinase inhibitor (CDKI) -p21
Waf1/Cip1 is a calcitriol-responding gene with three VDREs within the promoter [13] . Therefore, calcitriol may directly activate its transcription inducing the cell cycle arrest in the G0/G1 phase [14] . We recently reported that PRI-2191 alone and in combination with 5-FU arrests HT-29 cells cycle in G0/G1 phase with a parallel decrease of cells percentage in the S stage [3] . For this reason, we hypothesized that the potentiation of 5-FU anticancer activity by PRI-2191 is related to the induction of CDKN1A expression in a VDR-dependent manner and consequently downregulation of the TS expression. TS plays an important role in the process of DNA synthesis and is the molecular target for 5-FU. The active metabolite of 5-FU, fluorodeoxyuridine monophosphate (FdUMP), forms a ternary complex with TS as well as 5,10-methylenetetrahydrofolate (CH2THF) and consequently inhibits the enzymatic activity of TS [15, 16] . However, overexpression of TS decreases the efficacy of 5-FU and this is one of the main reasons of resistance of CRC cells to this chemotherapeutic agent [16, 17] . Thus, anticancer efficacy of 5-FU may be improved by preventing TS expression [16] .
The literature data indicate that also survivin (a key anti-apoptotic protein), epithelialmesenchymal transition (EMT) and autophagy contribute to the development of resistance of cancer cells to 5-FU [15, 18, 19] . Therefore, the inhibition of survivin expression, EMT and autophagy may help prevent the development of resistance of CRC cells to 5-FU treatment.
The aim of the present studies was to evaluate the mechanism underlying the enhancement of 5-FU activity by PRI-2191 against human HT-29 CRC cells. We investigated 
Material and methods

Cell lines culture
The human HT-29 CRC cell line was purchased from the American Type Culture Collection Chalfont, UK) and 1 mM sodium pyruvate (Sigma-Aldrich, Poznan, Poland). All culture media were supplemented with antibiotics: 100 μg/ml streptomycin (Sigma-Aldrich, Poznan, Poland) and 100 U/ml penicillin (Polfa Tarchomin, Warsaw, Poland). In all experiments the cell lines
were cultured in a humid atmosphere at 37 C with 5% CO2 and passaged twice a week using trypsin-EDTA solution (IIET, Wroclaw, Poland) as a detachment agent.
Compounds
Vitamin D3 metabolites such as calcitriol [1,25- 
Colorectal cancer cell line HT-29 transduction
The third-generation lentiviral system consisting of pMDLg/pRRE, pRSV-Rev, pMD2.G (the using Prolab-3 system based on Cheburator software described by Nevozhay [22] .
MTT assay
MTT assay was used as previously described by Mosmann [23] (v/v). It did not show any effect on the cellular processes. Following incubation, the cells were subjected to the procedures described below.
Real-time PCR
TYMS, CDKN1A, BIRC5 and VDR gene expression
After incubation, the cells were washed twice in PBS, collected in TRI Reagent (Sigma-Aldrich, Poznan, Poland) and kept at -80°C for further analysis. After the samples thawed, chloroform 3B ) was calculated also relative to the average of the two (HPRT and Rpl13a) or three (GAPDH,
HPRT and Rpl13a) endogenous controls and results were obtained with a similar trend as after normalization to HPRT mRNA.
Western blot
After incubation, the cells were washed twice in PBS (IIET, Wroclaw, Poland) and lysed in RIPA buffer supplemented with protease inhibitor cocktail (both Sigma-Aldrich, Poznan, Poland). Cell lysates were purified by centrifugation for 10 min at 4°C and 10,000 x g and then supernatants were transferred to new tubes. Total protein concentration in cell lysates was analyzed using the modified Lowry method (Bio-Rad, Warsaw, Poland) according to the manufacturer's protocol.
TS, E-cadherin, N-cadherin, ZO-1 and VDR protein expression
Samples containing 50 µg of proteins were denatured in 4X Laemmli Sample Buffer (Bio-Rad, Warsaw, Poland) supplemented with β-mercaptoethanol (Sigma-Aldrich, Poznan, Poland) for 5 min at 95°C and then separated in 7.5% (E-cadherin, N-cadherin, ZO-1, VDR, β-actin) or in 15% (TS, β-actin) sodium dodecyl sulphate-polyacrylamide (SDS-PAGE) gels. After electrophoresis, the proteins were transferred from gels to polyvinylidene difluoride 
Cell staining with acridine orange for autophagy detection
The volume of cellular acidic compartment (marker of autophagy) was quantified by acridine orange staining [24] . After 120 h (5 d) of incubation, the cells were collected using trypsin- Jose, CA, USA) at an excitation wavelength of 488 nm and data were analyzed using BD FACS Diva 6.2 software. The mean intensity of red fluorescence which is proportional to the volume of cellular acidic compartment was calculated for each experiment separately.
Statistical analysis
Statistical analysis was performed using the GraphPad Prism 7 (GraphPad Software, Inc., USA 
Results
Evaluation of cell cycle and cell death markers in human HT-29 CRC cells
The CDKN1A, TYMS, BIRC5 (real-time PCR), TS (western blot) expression and autophagy mRNA compared to control (Fig. 1A) . Calcitriol and PRI-2201 showed a similar but weaker effect than PRI-2191, while PRI-2205 did not show such activity. 5-FU applied alone revealed a tendency to upregulate CDKN1A expression. Additionally, a significant downregulation of TYMS mRNA level using PRI-2191 or its combination with 5-FU compared to control or 5-FU
was showed (Fig. 1B) . The similar tendency but not in a statistically significant manner was observed at the protein level (Fig. 1C) . While, 5-FU applied alone strongly increased the expression of TS protein compared to control (Fig. 1C) . Calcitriol and PRI-2201 or their combinations with 5-FU showed a similar but weaker effect than PRI-2191, while PRI-2205
did not influence the TYMS mRNA expression (Fig. 1B) . Furthermore, a significant decrease of BIRC5 gene expression by PRI-2191 compared to control was also observed (Fig. 1D ).
Calcitriol and PRI-2201 showed similar effect as PRI-2191 but not in a statistically significant manner. PRI-2205 did not influence the BIRC5 gene expression. No significant differences between 5-FU alone and in combination with VDAs in the case of BIRC5 mRNA level were observed. It was also showed that 5-FU alone strongly induced autophagy, whereas PRI-2191 diminished this effect. The same tendency was observed in the case of calcitriol and PRI-2201
but not PRI-2205 (Fig. 1E ).
Expression of the EMT markers and the tight junction-associated protein in human HT-29 CRC cells
The level of E-and N-cadherin (the markers of EMT) and also ZO-1 (the tight junction protein)
in HT-29 cells upon exposure to VDAs or their combination with 5-FU was evaluated using western blot method. PRI-2191 alone and also in combination with 5-FU showed a tendency to elevate E-cadherin level compared to control and 5-FU alone. However, 5-FU induced statistically significant increase of N-cadherin compared to control but PRI-2191 inhibited this effect ( Fig. 2A) . The estimated E-cadherin to N-cadherin ratio in the cells exposed to PRI-2191 along with 5-FU was more than thrice as high as in the cells exposed to 5-FU alone. The same tendency was observed in the case of calcitriol or PRI-2201 combined with 5-FU but not for PRI-2205 (Fig. 2B) . Moreover, PRI-2191 alone and in combination with 5-FU increased the level of ZO-1 compared to control and 5-FU alone, but PRI-2205 did not show such activity (Fig. 2C) . 
Discussion
Our previous in vivo studies showed that two synthetic VDAs, namely PRI-2191 and PRI-2205 [5,6- efficacy of TYMS mRNA [25] . The translation of TYMS mRNA is regulated by its own TS protein product in a negative autoregulatory manner [26] . The TS in the complex with FdUMP and CH2THF is not able to bind its own mRNA and block its translation. Therefore, the level of TS protein increases in cells exposed to 5-FU [27] which is the main reason of treatment failure. Accordingly, we observed that 5-FU applied alone significantly increased the level of TS protein, while PRI-2191 inhibited this effect. Additionally, PRI-2191 alone and in combination with 5-FU downregulated the TYMS mRNA, while 5-FU alone did not affect the TYMS transcription. We also showed that PRI-2191 significantly increased the expression of CDKN1A gene which encodes the cell cycle inhibitor p21 Waf1/Cip1 . The progression of cell cycle is promoted by cyclin-dependent kinases (CDKs) which are positively and negatively regulated by cyclins and cyclin-dependent kinase inhibitors (CDKIs), respectively [28] . Cyclin E with CDK2 is active at the G1-S transition and directs cells into S-phase [28] . The CDKI -p21
Waf1/Cip1 negatively regulates cyclin E/CDK2 complex and thus blocks phosphorylation of the retinoblastoma protein (Rb). Phosphorylation of Rb is required to release E2F-1 transcription factor which plays a key role in the induction of genes expression required for the cells transition from G1 to S phase including TYMS gene [28, 29] . Accordingly, we showed that PRI- 
CDKI -p21
Waf1/Cip1 [30] . In addition, they showed that synthetic CDKI reduces the expression of TS and thus enhances human DLD-1 CRC cells sensitivity to 5-FU [30] .
The transcription of CDKN1A gene is regulated mainly by p53 protein [13] . However, it was showed that there are VDREs within the promoter of CDKN1A and thus vitamin D can induce its expression [13] . This is important especially in the case of patients with a mutated form of p53. In addition, patients with mutated p53 show significantly higher level of TS than patients with wild type p53 [31] . In this paper we demonstrated that PRI-2191 downregulated the TS in HT-29 CRC cells which according to the literature data express mutated p53 [32] . We also noticed that PRI-2191 induced the expression of CDKN1A through the activation of VDR.
HT resistance by CRC cells [33] . Other experimental data have indicated that VDR interacts with Src and forms a VDR/Src complex [34] . Additionally, calcitriol promotes the complex formation between VDR and Src [34] . In the light of these results, we suppose that in the absence of VDR the level and the activity of Src increases, and this leads to upregulation of TYMS mRNA in CRC cells after exposure to 5-FU. In addition, the VDR activated by PRI-
have also reported that increased TYMS expression induces genotypic and phenotypic changes involved in the EMT [33] . The EMT is a process that facilitates the spread of cancer cells from the site of the primary tumor to the surrounding tissues and distant organs [35] . During EMT, E-cadherin is downregulated while N-cadherin is upregulated, which consequently leads to the change of cells phenotype from immobile epithelial to invasive mesenchymal cells [36] . In our studies, we observed an enhanced ratio of E-cadherin to N- calcitriol can directly induce its expression [43] . Furthermore, the literature data indicate the relationship between the level of CaSR and sensitivity of CRC cells to calcitriol [44] . Therefore, shown that CYP24A1 protein is highly expressed in cells which lack the CaSR [45, 46] . Thus, PRI-2191 can undergo inactivation, but this requires further investigation.
Conclusions
Taken together, PRI-2191 induces CDKN1A expression directly through VDR in a p53-independent manner and thus decreases TS expression both at the mRNA and protein level. 
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